Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Kitron: Key information relating to the cash dividend to be paid by Kitron ASA
-
Key information relating to the proposed cash dividend to be paid by NORBIT ASA
-
EU’s Urban Wastewater Treatment Directive could lead to additional costs of nearly EUR 1 billion in Finland alone, posing a serious threat to medicine availability
-
Solid 2024 performance; executing on plan to accelerate growth
-
Kojamo plc’s Financial Statements Release 1 January–31 December 2024
-
Start of Day Message
-
Arcadis Q4 and Full Year 2024 Results: Record earnings per share, record backlog, enhanced long term visibility
-
Press Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study
-
LHV Group financial plan for 2025 and the five-year financial forecast
-
Kitron: Q4 2024 - Profitable execution in a shifting market
-
NORBIT – Record Full-Year and Fourth Quarter Results 2024
-
Lassila & Tikanoja plc: Financial Statements Release 1 January–31 December 2024
-
Santhera Announces Agreement with German GKV-SV on Reimbursement Amount for AGAMREE® (vamorolone) for the Treatment of Duchenne Muscular Dystrophy in Germany
-
KBC Group: Fourth-quarter result of 1 116 million euros
-
Unaudited financial results of Coop Pank for Q4 and 12 months of 2024
-
The net asset value of EfTEN Real Estate Fund AS shares as of 31.01.2025
-
DNO Shares Traded Ex-Dividend
-
Ipsen delivers solid results in 2024, driven by strong performance across all therapeutic areas, and provides guidance for 2025
-
Central Bank of Savings Banks Finland Plc: Savings Banks Group’s Release of Financial Statements for 2024
-
Central Bank of Savings Banks Finland Plc: Annual Financial Report 2024
-
Sp Mortgage Bank Plc: Savings Banks Group’s Release of Financial Statements for 2024
-
Sp Mortgage Bank Plc: Annual Financial Report 2024
-
atai Life Sciences Announces Pricing of Public Offering of Common Shares
-
Euronet Reports Record Results Across All Financial Metrics For The Fourth Quarter And Full Year 2024
-
Aardvark Therapeutics Announces Pricing of Initial Public Offering
-
Nokia and Cellcard upgrade residential fiber broadband network in Cambodia
-
FSIS Recall Release 005-2025 - Produced Without the Benefit of Inspection
-
HostColor Announces New AMD Dedicated Server Infrastructure Options
-
Madison Pacific Properties Inc. declares dividend
-
Clark Joins Sonoco Board of Directors
-
Sonoco Declares Regular Quarterly Common Stock Dividend
-
FOBI AI Inc. Announces Proposed Variation to Private Placement
-
GoldQuest Grants Stock Options; Appoints Investor Relations Consultant
-
NASM Launches New Understanding Weight Loss Medications Course
-
AIP Realty Trust Closes Non-Brokered Offering of Preferred Units
-
Community Hospital Corporation and CarePilot Forge Strategic Partnership Following Successful Pilot of Ambient AI Technology
-
Precision Drilling Announces 2024 Fourth Quarter and Year End Unaudited Financial Results
-
Copa Holdings Reports Fourth-Quarter Financial Results
-
BCH Miner — The world's leading clean energy cloud mining platform, providing free mining
-
CarePilot and Community Hospital Corporation Forge Strategic Partnership Following Successful Pilot of Ambient AI Technology
-
Parker Scheduled to Present at Barclays Industrial Select Conference on February 19 at 11:00 a.m. Eastern Time
-
Parker Scheduled to Present at Barclays Industrial Select Conference on February 19 at 11:00 a.m. Eastern Time
-
THE ANNOUNCEMENT on the holding of the extraordinary general meeting
-
SmartCentres Real Estate Investment Trust Releases Fourth Quarter and Full Year Results for 2024
-
Ponce De Leon Foundation Grant Awarded in the Amount of $610,000 to Nonprofits
-
MGO Global Issues Reminder for Special Meeting of Stockholders to Vote on Approval of Business Combination Agreement with Heidmar
-
Partners Value Investments Inc. Announces Normal Course Issuer Bids
-
Avista Corp. Board Increases Common Stock Dividend
-
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
